Baik, Christina,
Update on EGFR-mutated non-small cell lung cancer [electronic resource] / Christina Baik. - London : Henry Stewart Talks, 2019. - 1 online resource (1 streaming video file (29 min.) : color, sound). - The biomedical & life sciences collection, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Lung cancer occurrence and distribution -- Effectiveness of targeted therapies -- Exon 20 mutations -- Common mechanisms of resistance -- Osimertinib as a treatment for T790M -- MET and C797S mutations -- Current treatment approaches -- Ongoing questions faced by the NSCLC community.
Access restricted to subscribers.
Mode of access: World Wide Web.
5064 Henry Stewart Talks
Antineoplastic agents.
Drug targeting.
Lungs--Cancer--Chemotherapy.
Lungs--Cancer--Genetic aspects.
Personalized medicine.
Antineoplastic Agents--therapeutic use.
Carcinoma, Non-Small-Cell Lung--drug therapy.
Carcinoma, Non-Small-Cell Lung--genetics.
Clinical Trials as Topic.
ErbB Receptors--physiology.
Exons.
Lung Neoplasms--drug therapy.
Lung Neoplasms--genetics.
osimertinib.
Piperazines.
Precision Medicine.
Update on EGFR-mutated non-small cell lung cancer [electronic resource] / Christina Baik. - London : Henry Stewart Talks, 2019. - 1 online resource (1 streaming video file (29 min.) : color, sound). - The biomedical & life sciences collection, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Lung cancer occurrence and distribution -- Effectiveness of targeted therapies -- Exon 20 mutations -- Common mechanisms of resistance -- Osimertinib as a treatment for T790M -- MET and C797S mutations -- Current treatment approaches -- Ongoing questions faced by the NSCLC community.
Access restricted to subscribers.
Mode of access: World Wide Web.
5064 Henry Stewart Talks
Antineoplastic agents.
Drug targeting.
Lungs--Cancer--Chemotherapy.
Lungs--Cancer--Genetic aspects.
Personalized medicine.
Antineoplastic Agents--therapeutic use.
Carcinoma, Non-Small-Cell Lung--drug therapy.
Carcinoma, Non-Small-Cell Lung--genetics.
Clinical Trials as Topic.
ErbB Receptors--physiology.
Exons.
Lung Neoplasms--drug therapy.
Lung Neoplasms--genetics.
osimertinib.
Piperazines.
Precision Medicine.